HeLa
Human Cervical Carcinoma cells
|
|
. |
Viability: 95%
|
Transfection Efficiency: 95%
|
| . |
. |
TIG-7
Human Embryonic Lung Fibroblasts
|
. |
. |
Viability 89%
|
Transfection Efficiency 76%
|
| . |
. |
MRC-5
Human Embryonic Lung Fibroblasts
|
 |
 |
Viability 85%
|
Transfection Efficiency 90%
|
| . |
. |
SUSM-1
Human Fibroblasts
|
 |
 |
Viability 77%
|
Transfection Efficiency 71%
|
| . |
. |
KMST-6
Human Fibroblasts
|
 |
 |
Viability 70%
|
Transfection Efficiency 60%
|
| . |
. |
HT1080
Human Fibrosarcoma cells
|
 |
 |
Viability 93%
|
Transfection Efficiency 81%
|
| . |
. |
MIA-PaCa-2
Human Pancreatic Carcinoma cells
|
 |
 |
Viability 80%
|
Transfection Efficiency 77%
|
| . |
. |
HepG2
Human Hepatoma cells
|
 |
 |
Viability 88%
|
Transfection Efficiency 76%
|
.
|
. |
Mutu
Human Burkitt Lymphoma cells
|
 |
 |
Viability 87%
|
Transfection Efficiency 91%
|
| . |
. |
TE-1
Human Esophageal Carcinoma cells
|
 |
 |
Viability 85%
|
Transfection Efficiency 41%
|
| . |
. |
TE-8
Human Esophageal Carcinoma cells
|
 |
 |
Viability 85%
|
Transfection Efficiency 40%
|
| . |
. |
OVCAR-3
Human Ovarian Carcinoma cells
|
 |
 |
Viability 90%
|
Transfection Efficiency 79%
|
| . |
. |
RMG-1
Human Ovarian Clear Cell Adenocarcinoma
|
 |
 |
Viability 97%
|
Transfection Efficiency 67%
|
| . |
. |
SK-N-SH
Human Neuroblastoma cells
|
 |
 |
| Blue: TO-PRO Green: GFP |
|
Viability 95%
|
Transfection Efficiency 95%
|
| . |
KG-1-C
Human Oligodendroglial cells
|
 |
 |
Viability 85%
|
Transfection Efficiency 60%
|
| . |
. |
HaCaT
Human Keratinocyte cells
|
 |
 |
Viability 40%
|
Transfection Efficiency 80%
|
| . |
. |
CCD1079sk
Human Skin Fibroblasts
|
 |
 |
Viability 40%
|
Transfection Efficiency 53%
|
| . |
. |
HTR-8/Svneo
Human Trophoblast cells
|
 |
 |
Viability 95%
|
Transfection Efficiency 67%
|
| . |
. |
MC3T3-E1
Mouse Osteoblastic cells
|
 |
 |
Viability 40%
|
Transfection Efficiency 80%
|
| . |
. |
MIN6
Mouse Pancreatic Beta cells
|
 |
 |
Viability 57%
|
Transfection Efficiency 71%
|
| . |
. |
XS106
Mouse Dendritic Cells
|
 |
Viability 61%
|
Transfection Efficiency 45%
|
| . |
. |
TS
Mouse Trophoblast Stem cells
|
 |
 |
Viability 59%
|
Transfection Efficiency 47%
|
| . |
. |
H9c2
Rat Ventricular Myoblasts
|
 |
 |
Viability 71%
|
Transfection Efficiency 82%
|
| . |
. |
L
Mouse Fibroblasts
|
 |
 |
Viability 90%
|
Transfection Efficiency 65%
|
| . |
. |
REF
Rat Embryonic Fibroblasts
|
 |
 |
Viability 90%
|
Transfection Efficicency 99%
|
| . |
. |
C6
Rat Glioma cells
|
 |
 |
Viability 80%
|
Transfection Efficiency 67%
|
| . |
. |
CHO
Chinese Hamster Ovary cells
|
 |
 |
Viability 74%
|
Transfection Efficiency 90%
|
| . |
. |
CHO-K1
Chinese Hamster Ovary cells
|
 |
 |
Viability 95%
|
Transfection Efficiecncy 95%
|
| . |
. |
DT40
Chicken B cells
|
 |
 |
Viability 38%
|
Transfection Efficiency 40%
|
| . |
. |
GTS9
Ginbuna Thymus cells
|
 |
 |
Viability 50%
|
Transfection Efficiency 30%
|
| . |
. |
Primary HASM
Human Airway Smooth Muscle cells
|
 |
 |
Viability 90%
|
Transfection Efficiency 80%
|
| . |
. |
Primary
Human Endometrial Stromal Cells
|
 |
 |
Viability 95%
|
Transfection Efficiency 90%
|
| . |
. |
Primary
Human Uterine Cervical Fibroblast
|
 |
 |
Viability 65%
|
Transfection Efficiency 90%
|
| . |
. |
Primary
Mouse Cerebral Cortex Neurons
|
 |
 |
9 days after EP
Red: MAP2 Blue: GFAP Green: GFP The cells were from Embryonic Day 14 Mouse Cerebral Cortex
|
Viability 80%
|
Transfection Efficiency 70%
|
| . |
. |
Primary
Mouse Microglia cells
|
 |
 |
Viability 65%
|
Transfection Efficiency 23%
|
| . |
. |
Primary BMMC
Mouse Bone Marrow-Derived Mast Cells
|
 |
 |
Viability 64%
|
Transfection Efficiency 78%
|
| . |
. |
Mouse iPS cells
|
 |
Viability 89%
|
Transfection Efficiency 47%
|
| . |
. |
Primary
Rat Bubblar Neurons
|
|
 |
7 days after EP / The cells were from Embryonic Day 15 Rat Bubblar Neurons
|
Viability 80%
|
Transfection Efficiency 75%
|
| . |
. |
Primary
Rat Meningeal Fibroblasts
|
 |
 |
Viability 90%
|
Transfection Efficiency 95%
|
| . |
. |
OEC
Rat Olfactory Ensheathing Cells
|

|
 |
The cells are from Postnatal Week 3 and were cultured for 2 weeks.
|
Viability 93%
|
Transfection Efficiency 46%
|
| . |
. |
Mouse TT2 ES Cells
|
 |
 |
Viability 55%
|
Transfection Efficiency 55%
|
| . |
. |
PC12
Rat Adrenal Pheochromocytoma Cells
|
|
Viability 70%
|
Transfection Efficiency 50%
|
| . |
. |
ddy Mouse Endometrial Cells
|
 |
 |
Viability 60%
|
Transfection Efficiency 80%
|
| . |
. |
RAW264.7
Mouse Macrophage-like Cells
|
 |
 |
Viability 70%
|
Transfection Efficiency 56%
|
| . |
. |
Primary Mouse Neurons in Adherence
|
 |
 |
|
|
 |
 |
|
|
 |
 |
|
|
|
|
|
|
|
|